{"entity":{"type":"insider","cik":"0001790880","url":"/insider/0001790880","json_url":"/insider/0001790880.json","name":"FHMLS X, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2020-12-11","last":"2025-09-30","span_basis":"filed_date"},"name_variants":[{"name":"FHMLS X, L.P.","source":"filing","n_filings":5,"first_seen":"2020-12-11","last_seen":"2025-09-30"}],"transactions":[{"id":5072229,"accession":"0001231919-25-000267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000267","line_url":"/filing/0001231919-25-000267#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.P.; Frazier Life Sciences X, L.P.; Topper James N; FHMLS X, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":11999988.0,"total_display":"11,999,988.00","shares_owned_after":5219440.0,"shares_owned_after_display":"5,219,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-30","scope":"insider"},{"id":2037681,"accession":"0000950170-24-107536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-107536","line_url":"/filing/0000950170-24-107536#line-2","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.L.C.; FHMLS X, L.P.; Frazier Life Sciences X, L.P.; Topper James N","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":4552774.0,"shares_owned_after_display":"4,552,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2278334,"accession":"0001415889-24-010490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010490","line_url":"/filing/0001415889-24-010490#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"HilleVax, Inc.","issuer_ticker":"HLVX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.L.C.; Heron Patrick J; FHMLS X, L.P.; Topper James N","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8850.0,"shares_display":"8,850","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":128325.0,"total_display":"128,325.00","shares_owned_after":8544187.0,"shares_owned_after_display":"8,544,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":6670086,"accession":"0000899243-22-016310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-016310","line_url":"/filing/0000899243-22-016310#line-2","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"HilleVax, Inc.","issuer_ticker":"HLVX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Heron Patrick J; FHMLS X, L.P.; Frazier Life Sciences X, L.P.; Topper James N; FHMLS X, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1764706.0,"shares_display":"1,764,706","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":30000002.0,"total_display":"30,000,002.00","shares_owned_after":8535337.0,"shares_owned_after_display":"8,535,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-03","filed_date":"2022-05-03","scope":"insider"},{"id":2922691,"accession":"0001104659-20-134761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-134761","line_url":"/filing/0001104659-20-134761#line-2","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Frazier Lifesciences Acquisition Corp","issuer_ticker":"FLAC","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.L.C.; Frazier Lifesciences Sponsor LLC; Topper James N; Heron Patrick J; Frazier Life Sciences X, L.P.; FHMLS X, L.P.","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":1000000.0,"shares_owned_after_display":"1,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Ten percent owner","n_filings":2,"first_seen":"2024-09-17","last_seen":"2025-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001888012","name":"HilleVax, Inc.","url":"/issuer/0001888012","role":"Ten percent owner","n_filings":2,"first_seen":"2022-05-03","last_seen":"2024-04-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001828326","name":"Frazier Lifesciences Acquisition Corp","url":"/issuer/0001828326","role":"Director","n_filings":1,"first_seen":"2020-12-11","last_seen":"2020-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001790880","retrieved_at":"2026-08-21T14:23:44+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}